- US12116636utility2024Methods for Evaluating Tumor Cell Spheroids Using 3D Microfluidic Cell Culture Device0 cites
- US12109212utility2024Methods of Treating Cancer Having an Active Wnt/β-catenin Pathway0 cites
- US12109266utility2024Modulating Gabarap to Modulate Immunogenic Cell Death0 cites
- US12110292utility2024Ligands to Cereblon (CRBN)0 cites
- US12103972utility2024KIR3DL3 as an HHLA2 Receptor, Anti-hhla2 Antibodies, and Uses Thereof0 cites
- US12098154utility2024Inhibitors of Cyclin-dependent Kinases0 cites
- US12076390utility2024Humanized Influenza Monoclonal Antibodies and Methods of Use Thereof0 cites
- US12060366utility2024Bispecific Degraders0 cites
- US12053476utility2024Compounds, Compositions and Methods for Cancer Patient Stratification and Cancer Treatment0 cites
- US12050219utility2024Modulating Biomarkers Such as SPP to Increase Tumor Immunity and Improve the Efficacy of Cancer Immunotherapy0 cites
- US12042513utility2024Proteolysis Targeting Chimeric Molecules (protacs) with Functional Handles and Uses Thereof0 cites
- US12043870utility2024Methods and Compositions for Detecting and Modulating an Immunotherapy Resistance Gene Signature in Cancer0 cites
- US12030892utility2024CRBN Modulators0 cites
- USRE050030reissue2024Methods to Treat Lymphoplasmacytic Lymphoma0 cites
- US12023385utility2024Tunable Endogenous Protein Degradation with Heterobifunctional Compounds0 cites
- US12018080utility2024Methods and Compositions for Treating Cancer by Targeting the CLEC2D-KLRB1 Pathway0 cites
- US12006555utility2024Method to Determine Responsiveness of Cancer to Epidermal Growth Factor Receptor Targeting Treatments0 cites